Studies on virus-inhibiting factor or interferon
Nagano, Y.
Kitasato Archives of Experimental Medicine 54(1-2): 1-15
1981
ISSN/ISBN: 0023-1924 PMID: 6182340 Document Number: 180302
Document emailed within 1 workday
Related Documents
Higashihara, M.; Koyama, H.; Igarashi, Y. 1972: Induction of virus-inhibiting factor or interferon in mice by strains with different virulence of Rift Valley fever virus Kitasato Archives of Experimental Medicine 45(1): 33-43Mathew, T.; Kulkarni, M.P. 1970: Cultivation and immunological studies on pox groups of viruses. Interference of pox viruses by Ranikhet virus interferon like factor Indian Veterinary Journal 47(4): 289-293
Christodoulopoulou, G.; Havredaki, M.; Christodoulopoulos, J. 1986: Virus-inhibiting factor in primary and metastatic carcinoma of the liver Cancer Detection and Prevention 9(3-4): 385-388
Hotta, S. 1978: Studies on virus-inhibiting substances of bacterial origin. I. Introduction Kobe Journal of Medical Sciences 24(2): 87-90
Melezyńska-Matej, M.; Grzybek-Hrynewicz, K.; Kotlarek-Haus, S.; Kaiser, A. 1981: Studies on phagocytosis in leukaemia. III. Phagocytosis inhibiting factor in sera of leukaemic patients Folia Haematologica 108(4): 559-566
Togashi, H.; Ohno, S.; Matsuo, T.; Watanabe, H.; Saito, T.; Shinzawa, H.; Takahashi, T. 2000: Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress Research Communications in Molecular Pathology and Pharmacology 107(5-6): 407-417
Onozaki, K.; Urawa, H.; Tamatani, T.; Iwamura, Y.; Hashimoto, T.; Baba, T.; Suzuki, H.; Yamada, M.; Yamamoto, S.; Oppenheim, J.J. 1988: Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor Journal of Immunology 140(1): 112-119
Vettukattil, J.J. 2017: Is the Hepatic Factor a miRNA that Maintains the Integrity of Pulmonary Microvasculature by Inhibiting the Vascular Endothelial Growth Factor? Current Cardiology Reviews 13(3): 244-250
Sakuma, I.; Enomoto, N.; Asahina, Y.; Kurosaki, M.; Sato, C. 1995: Fluctuation of hepatitis C virus quasispecies with interferon treatment and interferon-resistant variants in hepatitis C virus 1b Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 930-935
Iwata, M.; Huff, T.F.; Ishizaka, K. 1984: Modulation of the biologic activities of IgE-binding factor. V. the role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors Journal of Immunology 132(3): 1286-1293
Bemelmans, M.H.; Gouma, D.J.; Buurman, W.A. 1993: LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma Journal of Immunology 151(10): 5554-5562
Vianello, F.; Tison, T.; Tagariello, G.; Zerbinati, P.; Zanon, E.; Scarano, L.; Girolami, A. 1999: Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 10(6): 393-397
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Gutman, N.R.; Manakhova, L.S. 1981: Ability of influenza virus strains to induce interferon and their sensitivity to the action of exogenous interferon Voprosy Virusologii 2: 168-171
Fleischmann, W.R.; Kleyn, K.M.; Baron, S. 1980: Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations Journal of the National Cancer Institute 65(5): 963-966
Filimonov, V.I. 1971: The factor inhibiting erythropoiesis Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 15(5): 57-60
Arrighi, S.; Rossi, R.; Borri, M.G.; Lesnikov, V.; Lesnikova, M.; Franco, E.; Divizia, M.; De Santis, M.E.; Bucci, E. 1995: "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate Thrombosis and Haemostasis 74(3): 868-873
Skibiński, G.; Zwoliński, J.; Wieczorek, Z. 1979: Modulation of e rosette forming activity of human lymphocytes by rosette inhibiting factor (RIF) ann rosette restoring factor (RRF) Archivum Immunologiae et Therapiae Experimentalis 27(4): 475-480
Van Damme, J.; De Ley, M.; Van Snick, J.; Dinarello, C.A.; Billiau, A. 1987: The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor Journal of Immunology 139(6): 1867-1872
Chemodanov, V.I.; Mikhal'skaia, E.V.; Sel'verova, N.B. 1977: Biological standardization of the gonadotropin-inhibiting factor Problemy Endokrinologii 23(6): 69-72